Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapeutic problems in pneumonia]

M Gonon1, W Zimmerli, P Dalquen

  • 1Departement für Innere Medizin, Universitätsklinik Basel.

Praxis
|October 3, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of medical decision support systems (DDX generators) using real medical cases of varying complexity and origin.

BMC medical informatics and decision making·2022
Same author

'Pathogenesis and management of fracture-related infection' - Author's reply.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Pathogenesis and management of fracture-related infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Debridement and implant retention in the management of hip periprosthetic joint infection: outcomes following guided and rapid treatment at a single centre.

The bone & joint journal·2017
Same author

The use of rifampin in staphylococcal orthopaedic-device-related infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

[Fine-needle aspiration (FNA) of the thyroid gland : Analysis of discrepancies between cytological and histological diagnoses].

Der Pathologe·2016
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Community-acquired pneumonia affects 1% of Swiss adults annually, often caused by Mycoplasma, influenza virus, and pneumococci. Treatment choice depends on patient immunity and causative agents, with careful diagnosis crucial if initial therapy fails.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) affects 10 out of 1000 adults in Switzerland annually.
  • Common causative agents include Mycoplasma, influenza virus, and Streptococcus pneumoniae.
  • Macrolides are the current first-line treatment for CAP caused by these pathogens.

Observation:

  • Pneumonia in immunocompromised patients requires consideration of Haemophilus influenzae and Klebsiella pneumoniae.
  • Recommended treatments for these cases include amoxicillin/clavulanic acid or second-generation cephalosporins.
  • Blindly altering empirical therapy upon failure is discouraged.

Findings:

  • Effective pneumonia management hinges on accurate etiological diagnosis and consideration of patient-specific factors, particularly immune status.

Related Experiment Videos

  • Differential diagnosis and targeted investigations are essential when initial empirical treatment proves ineffective.
  • Case studies highlight the complexities and potential pitfalls in treating pneumonia patients.

    • Implications:

    • Optimizing antibiotic selection based on likely pathogens and host factors can improve CAP treatment outcomes.
    • A systematic approach involving differential diagnosis is vital for managing refractory pneumonia cases.
    • Understanding specific etiological agents and patient immune status is key to successful pneumonia therapy.